Harding Loevner’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.7M | Sell |
139,791
-5,234
| -4% | -$2.84M | 0.71% | 49 |
|
|
2025
Q4 | $84M | Sell |
145,025
-23,551
| -14% | -$13.3M | 0.74% | 42 |
|
|
2025
Q3 | $81.8M | Sell |
168,576
-60,955
| -27% | -$28.4M | 0.6% | 46 |
|
|
2025
Q2 | $93.1M | Sell |
229,531
-187,050
| -45% | -$78.2M | 0.63% | 48 |
|
|
2025
Q1 | $207M | Sell |
416,581
-58,359
| -12% | -$31.6M | 1.59% | 26 |
|
|
2024
Q4 | $247M | Sell |
474,940
-93,562
| -16% | -$51.4M | 1.67% | 23 |
|
|
2024
Q3 | $352M | Buy |
568,502
+2,742
| +0.5% | +$1.62M | 2.03% | 16 |
|
|
2024
Q2 | $313M | Sell |
565,760
-19,456
| -3% | -$11.1M | 1.73% | 18 |
|
|
2024
Q1 | $340M | Sell |
585,216
-42,839
| -7% | -$24M | 2.1% | 18 |
|
|
2023
Q4 | $334M | Sell |
628,055
-11,639
| -2% | -$5.63M | 1.87% | 18 |
|
|
2023
Q3 | $324M | Buy |
639,694
+186,928
| +41% | +$99.6M | 2.14% | 14 |
|
|
2023
Q2 | $236M | Sell |
452,766
-85,424
| -16% | -$46.1M | 1.38% | 27 |
|
|
2023
Q1 | $310M | Buy |
538,190
+7,378
| +1% | +$4.16M | 1.77% | 21 |
|
|
2022
Q4 | $292M | Buy |
530,812
+58,654
| +12% | +$31.1M | 1.68% | 18 |
|
|
2022
Q3 | $239M | Sell |
472,158
-27,793
| -6% | -$15.6M | 1.57% | 20 |
|
|
2022
Q2 | $272M | Sell |
499,951
-14,068
| -3% | -$7.74M | 1.68% | 19 |
|
|
2022
Q1 | $267M | Sell |
514,019
-139,260
| -21% | -$80M | 1.47% | 23 |
|
|
2021
Q4 | $436M | Sell |
653,279
-13,378
| -2% | -$8.35M | 1.67% | 22 |
|
|
2021
Q3 | $381M | Sell |
666,657
-2,306
| -0.3% | -$1.27M | 1.52% | 26 |
|
|
2021
Q2 | $337M | Buy |
668,963
+83,211
| +14% | +$39.3M | 1.27% | 29 |
|
|
2021
Q1 | $267M | Sell |
585,752
-47,882
| -8% | -$22.9M | 1.05% | 30 |
|
|
2020
Q4 | $295M | Buy |
633,634
+11,036
| +2% | +$5.17M | 1.22% | 30 |
|
|
2020
Q3 | $275M | Buy |
622,598
+26,788
| +4% | +$11.1M | 0.99% | 33 |
|
|
2020
Q2 | $216M | Buy |
595,810
+595,750
| +992,917% | +$200M | 1.03% | 30 |
|
|
2020
Q1 | $17K | Hold |
60
| – | – | ﹤0.01% | 124 |
|
|
2019
Q4 | $19K | Hold |
60
| – | – | ﹤0.01% | 124 |
|
|
2019
Q3 | $17K | Hold |
60
| – | – | ﹤0.01% | 123 |
|
|
2019
Q2 | $18K | Hold |
60
| – | – | ﹤0.01% | 126 |
|
|
2019
Q1 | $16K | Hold |
60
| – | – | ﹤0.01% | 124 |
|
|
2018
Q4 | $13K | Hold |
60
| – | – | ﹤0.01% | 131 |
|
|
2018
Q3 | $15K | Hold |
60
| – | – | ﹤0.01% | 127 |
|
|
2018
Q2 | $12K | Hold |
60
| – | – | ﹤0.01% | 131 |
|
|
2018
Q1 | $12K | Hold |
60
| – | – | ﹤0.01% | 143 |
|
|
2017
Q4 | $11K | Hold |
60
| – | – | ﹤0.01% | 129 |
|
|
2017
Q3 | $11K | Hold |
60
| – | – | ﹤0.01% | 124 |
|
|
2017
Q2 | $10K | Buy |
+60
| New | +$10.1K | ﹤0.01% | 123 |
|
Other funds holding TMO
VCM
